Filter
3481
Filtered Results: 3481
Text search:
First
line
drug
management
Featured
Recommendations
363
New Publications
1069
Language
Document type
No document type
2141
Studies & Reports
472
Guidelines
464
Manuals
163
Strategic & Response Plan
133
Training Material
52
Fact sheets
30
Situation Updates
14
Infographics
5
Resource Platforms
4
Brochures
2
Online Courses
1
Countries / Regions
India
238
Kenya
123
Global
108
South Africa
100
Ethiopia
95
Uganda
92
Nigeria
81
Western and Central Europe
74
Nepal
73
Tanzania
71
Malawi
69
Sierra Leone
67
Liberia
60
Myanmar / Burma
57
Zambia
55
Namibia
53
Bangladesh
50
Ghana
47
Rwanda
44
Africa
41
Latin America and the Carribbean
35
Eastern Europe
35
South–East Asia Region
28
Zimbabwe
27
Cambodia
27
Philippines
26
Lesotho
25
Asia
25
Ukraine
22
Botswana
18
Indonesia
17
Syria
15
Congo, Democratic Republic of
14
Senegal
13
Mozambique
13
Eswatini/ Swaziland
12
Cameroon
11
Burkina Faso
11
East and Southern Africa
10
Eastern Europe and Central Asia
9
Tajikistan
8
Colombia
8
Vietnam
8
Russia
8
Pakistan
8
Thailand
7
Albania
7
Haiti
7
West and Central Africa
7
South Sudan
7
Benin
6
Laos
6
Afghanistan
6
Guinea
6
USA
6
Western Pacific Region
6
Sudan
6
China
5
Venezuela
5
Brazil
5
Moldova
5
Georgia
5
Iraq
5
Timor Leste/ East Timor
4
Turkey
4
Germany
4
Middle East and North Africa
4
United Kingdom
4
Sri Lanka
4
North Macedonia
3
Mexico
3
El Salvador
3
Iran
3
Fiji
3
Peru
3
Jordan
3
North America
3
Argentina
3
Lebanon
3
Papua New Guinea
3
Central African Republic
3
Bhutan
3
Somalia
3
Armenia
2
Jamaica
2
France
2
Spain
2
Côte d’Ivoire / Ivory Coast
2
Bolivia
2
Mali
2
North Korea
1
Switzerland
1
Gambia
1
Kazakhstan
1
Chile
1
Canada
1
Estonia
1
Kyrgyzstan
1
Congo-Brazzaville
1
Niger
1
Uzbekistan
1
Morocco
1
Bulgaria
1
Lithuania
1
Saudi Arabia
1
Paraguay
1
Gabon
1
Uruguay
1
Turkmenistan
1
Denmark
1
Maldives
1
Mauritius
1
Tunisia
1
Portugal
1
Nicaragua
1
Romania
1
Greece
1
Honduras
1
Libya
1
Madagascar
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
1536
Clinical Guidelines
339
Public Health
168
Women & Child Health
152
Key Resources
98
Capacity Building
61
Pharmacy & Technologies
40
Toolboxes
TB
382
HIV
354
Mental Health
245
AMR
187
NTDs
115
COVID-19
101
Pharmacy
95
Caregiver
68
Malaria
68
NCDs
63
Ebola & Marburg
43
Conflict
43
Rapid Response
39
Planetary Health
35
Refugee
29
Disability
27
Global Health Education
27
Health Financing Toolbox
24
Natural Hazards
18
Cholera
17
2.0 Rapid Response
17
Polio
16
Zika
9
Specific Hazards
8
Social Ethics
4
Pakistan Global Antibiotic Resistance Partnership (GARP) was formed in the wake of international and national efforts for AMR curtailment. A group of experts from microbiology, infectious diseases and veterinary medicine formed a core group at the organizational meet...
Priority medical devices list for the COVID-19 response and associated technical specifications
recommended
23 February 2021
This document describes the medical devices required for the clinical management of COVID-19, selected and prioritized according to the latest available evidence and interim guidelines. This includes: oxygen therapy, pulse oximeters, patient monitors, thermometers, infusion and suc...
The document is structured into five sections. The first presents the key experiences and challenges that justify a renewal of the EPHFs. The second section updates the groundwork for the exercise of public health and provides a framework to inform the exercise of the new essential functions. The th...
With its expert practical advice on security in situations of armed conflict, this updated set of guidelines will prove invaluable to humanitarian personnel working at the operational level. Following on from the success of the first edition, published in 1999, it addresses new and developing threat...
This National Action Plan addresses actions needed to be taken in order to combat antimicrobial resistance (AMR) in the country. It is obligatory to raise awareness of antimicrobial resistance and promote behavioral change through public communication
programmes that targets human, animal and plant...
The NDMS&IP focuses on mainstreaming disability to promote equitable access to services in the six thematic areas of health, education, livelihoods, empowerment, and social inclusion and cross-cutting issues.
The first part of the NDMS&IP outlines incongruences between national and sectoral policie...
In case of resistance to rifampicin, fluoroquinolones become the preferred category of second-line drugs. Unfortunately, quinolone-resistant strains of Mycobacterium leprae have also been reported in several countries, probably due to the extensive use of quinolones for treating several types of inf...
People affected by impairments and disabilities associated with TB are even more likely to belong to marginalized segments of society and are more likely to have their human rights unprotected. The challenges faced by people affected by TB include the consequences of impairment and disability associ...
This booklet is recommended for all health workers who diagnose and treat leprosy, especially those at the first referral level such as a health centre. It contains more detail than the WHO Guide to Eliminate Leprosy as a Public Health Problem. The Guide gives practical advice on how to diagnose lep...
In this guide, the African Palliative Care Association (APCA) has put together evidence‑based information on the use of specific opioids commonly used in the management of moderate‑to‑severe pain to manage both cancer and non‑cancer pain. APCA hopes that this guide will be a useful tool i...
The Democratic Republic of Timor-Leste has the highest TB incidence rate in the South East Asian Region - 498 per 100,000, which is the seventh highest in the world. In Timor-Leste TB is the eighth most common cause of death.
The salient observations are as follows:
In 2018, 487 (12.5%) of the...
There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to as Target Regimen Profiles or TRPs) seeks to guide the drug development process towards important regi...
The main objective of these guidelines is to provide guidance on up-to-date, uniform, evidence-informed practices for suspecting, diagnosing and managing various forms of extra-pulmonary tuberculosis (EPTB) at all levels of healthcare delivery. They can then contribute to the National Programme to i...
Despite the considerable improvement in global health, millions of people still lack access to quality health services, including access to effective antimicrobial medicines, or are impoverished as a result of health spending. At the same time, antimicrobial resistance – a consequence of overuse a...
The recommendations cover the level of blood pressure to start medication, what type of medicine or combination of medicines to use, the target blood pressure level, and how often to have follow-up checks on blood pressure. In addition, the guideline provides the basis for how physicians and other h...
2nd edition. These guidelines include several notable changes from the first edition. For cutaneous leishmaniasis, ketoconazole has been removed from the list of treatment options; the number of Leishmania species for which there is strong evidence for the efficacy of miltefosine has increased from ...
Version 10.1_5 October 2020
These Guidelines are available in different formats: As a paper booklet, a PDF, a mobile app, and now also as a website.
The 2019 version of the Guidelines introduces a new drug-drug interaction panel and now consists of six main sections, including a general overview ...
Review over the work and challenges of the Nigerian National Agency for Food and Drug Administration and Control (NAFDAC) in combatting counterfeiting of medicines in Nigeria.
Namibia is estimated to be at 94-97-93 as defined by the UNAIDS 95-95-95 treatment cascade, one of the first high burden countries to approach epidemic control. COP22 is about sustaining the impact of years of investment and partnership with the Namibian government and other stakeholders by employin...
The National Strategic Plan on Malaria Prevention and Elimination Period 2021 – 2025 seeks to build on the previous national successes of the National Institute of Malariology, Parasitology, and Entomology (NIMPE) while addressing current challenges to reduce the overall burden of malaria in the S...
